Search results for "Angiotensin-Converting Enzyme"

showing 10 items of 159 documents

Verlaufsbeobachtung von Patienten mit chronischer Aortenklappeninsuffizienz unter ACE-Hemmer-Therapie (Follow-up of patients with chronic severe aort…

1997

In dieser Untersuchung wurde der Einflus einer 3monatigen ACE-Hemmer-Therapie mit Cilazapril (2,5–5 mg) bei 13 Patienten mit chronischer Aortenklappeninsuffizienz spiroergometrisch und echokardiographisch untersucht. Nach 3monatiger Therapie sanken der linksventrikulare enddiastolische Diameter-Index von 3,5 auf 3,1 cm/m2 (p = 0,005), der linksventrikulare endsystolische Diameter-Index von 2,3 auf 2,0 cm/m2 (p = 0,005). Der Wallstress reduzierte sich von 174 auf 150 dyn/cm2 (p = 0,01). Die linksventrikulare Muskelmasse nahm um 14% ab, von anfangs 570 g (= 295 g/m2) auf 488 g (= 253 g/m2) (p < 0,05). Die von apikal gemesesene Jetflache reduzierte sich von 10,1 auf 8,1 cm2 (p < 0,05). Weder d…

Gynecologymedicine.medical_specialtyInsuficiencia aorticabiologybusiness.industryPeptidyl-Dipeptidase AFollow up studiesAngiotensin-converting enzymeCilazaprilValvula aorticamedicinebiology.proteinCardiology and Cardiovascular Medicinebusinessmedicine.drugZeitschrift f�r Kardiologie
researchProduct

Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMI

2020

Abstract Use of renin-angiotensin-aldosterone system inhibitors (RAASi) in patients with heart failure (HF) and reduced ejection fraction is associated with functional improvement, an increase in perceived quality of life, a reduction in the probability of cardiovascular death, and a decrease in the number of hospitalizations. Some of these drugs are also efficacious in patients with chronic kidney disease and albuminuria as well as in patients with resistant hypertension. Despite their numerous benefits, RAASi are associated with an increase in incidence of hyperkalemia, especially in patients with concomitant chronic kidney disease. Hyperkalemia is a common electrolyte disorder that is de…

Heart FailureMalemedicine.medical_specialtyConsensusEjection fractionHyperkalemiabusiness.industryIncidence (epidemiology)Angiotensin-Converting Enzyme InhibitorsGeneral Medicinemedicine.diseaseHeart failureConcomitantEmergency medicineQuality of LifemedicineAlbuminuriaHumansHyperkalemiaFemaleRenal Insufficiency Chronicmedicine.symptombusinessKidney diseaseElectrolyte DisorderRevista Clínica Española (English Edition)
researchProduct

Influence of the i/d polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension

2000

The objective of the present study was to analyze the influence of the I/D polymorphism of the ACE gene on the outcome of microalbuminuria in essential hypertensive patients who were receiving antihypertensive treatment. One hundred thirty-six essential hypertensive patients who were <50 years old and had never previously received treatment with antihypertensive drugs were included in the study. During a 3-year period, patients received nonpharmacological treatment consisting of moderate salt restriction and a low-calorie diet they were obese, with or without a regimen of antihypertensive drugs based on ß-blockers or ACE inhibitors. Hydrochlorothiazide was added when necessary to maintain t…

Hypertension essential:CIENCIAS MÉDICAS ::Medicina interna [UNESCO]UNESCO::CIENCIAS MÉDICASGeneticsAlbuminuriaAngiotensin-converting enzyme geneHypertension essential ; Albuminuria ; Genetics ; Angiotensin-converting enzyme gene:CIENCIAS MÉDICAS [UNESCO]UNESCO::CIENCIAS MÉDICAS ::Medicina interna
researchProduct

The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries.

2021

While COVID-19 infection and mortality rates are soaring in Western countries, Southeast Asian countries have successfully avoided the second wave of the SARS-CoV-2 pandemic despite high population density. We provide a biochemical hypothesis for the connection between low COVID-19 incidence, mortality rates, and high visceral adiposity in Southeast Asian populations. The SARS-CoV-2 virus uses angiotensin-converting enzyme 2 (ACE2) as a gateway into the human body. Although the highest expression levels of ACE2 are found in people’s visceral adipose tissue in Southeast Asia, this does not necessarily make them vulnerable to COVID-19. Hypothetically, high levels of visceral adiposity cause s…

Intra-Abdominal FatHealth Toxicology and Mutagenesislcsh:MedicinePhysiologyAdipose tissueACE2030209 endocrinology & metabolismIntra-Abdominal FatPeptidyl-Dipeptidase ASoutheast asianSystemic inflammationWhite People03 medical and health sciences0302 clinical medicineAsian PeopleMedicineHumansObesityvisceral adipose tissuePandemicsAsia Southeastern030304 developmental biologyAdiposityInflammationsystemic inflammation0303 health sciencesbusiness.industrySARS-CoV-2Mortality rateIncidencelcsh:RCOVID-19 ; visceral adipose tissue ; systemic inflammation ; SARS-CoV-2 ; ACE2 ; weight gain ; second wave ; Quarantine-15Public Health Environmental and Occupational HealthCOVID-19weight gainmedicine.diseaseObesitysecond waveQuarantine-15PerspectiveAngiotensin-Converting Enzyme 2medicine.symptombusinessWeight gainObesity paradoxInternational journal of environmental research and public health
researchProduct

Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-…

2020

Since the end of 2019, the coronavirus SARS-CoV-2 has caused more than 1000000 deaths all over the world and still lacks a medical treatment despite the attention of the whole scientific community. Human angiotensin-converting enzyme 2 (ACE2) was recently recognized as the transmembrane protein that serves as the point of entry of SARS-CoV-2 into cells, thus constituting the first biomolecular event leading to COVID-19 disease. Here, by means of a state-of-the-art computational approach, we propose a rational evaluation of the molecular mechanisms behind the formation of the protein complex. Moreover, the free energy of binding between ACE2 and the active receptor binding domain of the SARS…

LetterPneumonia ViralProtein domainThermodynamicsPlasma protein bindingMolecular Dynamics SimulationPeptidyl-Dipeptidase ALigandsmedicine.disease_causeProtein-Protein Binding01 natural sciencesDockingBetacoronavirus03 medical and health sciencesProtein Domains0103 physical sciencesmedicineHumansGeneral Materials SciencePhysical and Theoretical ChemistryBinding siteReceptorPandemics030304 developmental biologyCoronaviruschemistry.chemical_classification0303 health sciencesBinding Sites010304 chemical physicsSARS-CoV-2Spike ProteinCOVID-19PlicamycinTransmembrane proteinEnzymechemistrySettore CHIM/03 - Chimica Generale E InorganicaMolecular Dynamics SimulationsSpike Glycoprotein CoronavirusAngiotensin-converting enzyme 2DiosminThermodynamicsAngiotensin-Converting Enzyme 2Coronavirus InfectionsProtein Binding
researchProduct

Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atom Simulations

2020

The severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic is setting the global health crisis of our time, causing a devastating societal and economic burden. An idiosyncratic trait of coronaviruses is the presence of spike glycoproteins on the viral envelope, which mediate the virus binding to specific host receptor, enabling its entry into the human cells. In spite of the high sequence identity of SARS-CoV-2 with its closely related SARS-CoV emerged in 2002, the atomic-level determinants underlining the molecular recognition of SARS-CoV-2 to the angiotensin-converting enzyme 2 (ACE2) receptor and, thus, the rapid virus spread into human body, remain unresolved. Here, multi-m…

LettervirusesAmino Acid MotifsPneumonia ViralVirus Attachment02 engineering and technologyPlasma protein bindingBiologyPeptidyl-Dipeptidase AMolecular Dynamics SimulationVirus03 medical and health sciencesBetacoronavirusViral ProteinsProtein structureViral envelopeGlobal healthHumansGeneral Materials SciencePhysical and Theoretical ChemistryReceptorProtein Structure QuaternaryPandemics030304 developmental biologyGlycoproteinschemistry.chemical_classificationGeneticsInfectivity0303 health sciencesSARS-CoV-2virus diseasesCOVID-19Hydrogen Bonding021001 nanoscience & nanotechnologySARS VirusProtein Structure TertiarySevere acute respiratory syndrome-related coronaviruschemistrySettore CHIM/03 - Chimica Generale E InorganicaQuantum TheoryAngiotensin-Converting Enzyme 20210 nano-technologyGlycoproteinCoronavirus InfectionsProtein Binding
researchProduct

Potentially inappropriate use of furosemide in a very elderly population: An observational study

2017

International audience; ObjectiveLittle is known about furosemide prescription modalities in elderly people. We describe furosemide prescription in ambulatory elderly patients.MethodsAll patients aged over 80 years, affiliated to Mutualité Sociale Agricole de Bourgogne, a French regional health insurance plan, with a medical prescription delivered in March 2015, were retrospectively included.ResultsAmong 15 141 patients with a median age of 86 years, comprising 61.3% of women, 3937 patients (26%) had a prescription for furosemide. Severe heart failure was the most common chronic comorbidity (27.7%). Furosemide was considered a long-term therapy for almost all patients (98.7% with prescripti…

Liver CirrhosisMalePediatricsmedicine.medical_specialtyAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsInappropriate Prescribing[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology030204 cardiovascular system & hematologyDrug PrescriptionsNephropathy03 medical and health sciences0302 clinical medicineFurosemidemedicineHumans030212 general & internal medicineMedical prescriptionRenal Insufficiency ChronicDiureticsRetrospective StudiesAged 80 and overHeart Failurebusiness.industryAge FactorsFurosemideRetrospective cohort studyGeneral Medicinemedicine.diseaseComorbidityHeart failureAmbulatoryObservational studyFemalebusinessmedicine.drug
researchProduct

Cross-sectional associations between angiotensin-converting enzyme inhibitor use and cancer diagnosis in US adults

2020

The objective of the present study was to investigate the association between angiotensin-converting enzyme (ACE) inhibitor use and cancer incidence (overall, and breast, prostate, and colorectal cancers specifically) in a large representative sample of US adults. Cross-sectional data on cancer diagnosis, timing of cancer diagnosis, ACE inhibitor use, and other characteristics were extracted from 49 512 adults aged ≥ 20 years participating in the National Health and Nutrition Examination Survey (1999–2016). Multivariable-logistic and propensity score matching (PSM) regressions examined the relationship between pre-diagnosis use of ACE inhibitors and diagnosis of all cancers, and breast, pro…

Male0301 basic medicineOncologyEpidemiology[SDV]Life Sciences [q-bio]Angiotensin-Converting Enzyme InhibitorsAngiotensin-converting enzyme inhibitors Cancer · Epidemiology NHANES · ObservationalProstate cancer0302 clinical medicineRisk FactorsSurveys and QuestionnairesObservationalCancerAged 80 and over2. Zero hungerbiologyIncidenceGeneral MedicineMiddle Aged3. Good health030220 oncology & carcinogenesisFemaleColorectal Neoplasmsmedicine.drugAdultmedicine.medical_specialtyNational Health and Nutrition Examination SurveyBreast NeoplasmsGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesInternal medicinemedicineNHANESHumansAgedbusiness.industryProstatic NeoplasmsCancerAngiotensin-converting enzymeOdds ratioAngiotensin-converting enzyme inhibitors Cancer Epidemiology NHANES Observationalmedicine.diseaseUnited StatesCross-Sectional StudiesLogistic Models030104 developmental biologyPropensity score matchingACE inhibitorbiology.proteinbusinessBody mass indexClinical and Experimental Medicine
researchProduct

Novel Antihypertensive Lactoferrin-Derived Peptides Produced by Kluyveromyces marxianus: Gastrointestinal Stability Profile and In Vivo Angiotensin I…

2014

Novel antihypertensive peptides released by Kluyveromyces marxianus from bovine lactoferrin (LF) have been identified. K. marxianus LF permeate was fractionated by semipreparative high performance liquid chromatography and 35 peptides contained in the angiotensin I-converting enzyme (ACE)-inhibitory fractions were identified by using an ion trap mass spectrometer. On the basis of peptide abundance and common structural features, six peptides were chemically synthesized. Four of them (DPYKLRP, PYKLRP, YKLRP, and GILRP) exerted in vitro inhibitory effects on ACE activity and effectively decreased systolic blood pressure after oral administration to spontaneously hypertensive rats (SHRs). Stab…

MaleAntihypertensive effectsAdministration OralAngiotensin-Converting Enzyme InhibitorsBlood PressurePeptideLactoferrin-derived peptidesPeptidyl-Dipeptidase AKluyveromycesKluyveromyces marxianusIn vivoRats Inbred SHRRenin–angiotensin systemAnimalsHumansKluyveromyces marxianusAmino Acid SequencePeptide sequenceAntihypertensive AgentsBiotransformationchemistry.chemical_classificationbiologyLactoferrinGastrointestinal digestionGeneral Chemistrybiology.organism_classificationAngiotensin IIRatsLactoferrinEnzymeBiochemistrychemistryHypertensionbiology.proteinCattlePeptidesGeneral Agricultural and Biological SciencesIn vivo ACE inhibition
researchProduct

Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease

2002

Epidemiological and pathogenetic evidences suggest a strong association between vascular risk factors and sporadic Alzheimer's disease (sAD). In agreement with the vascular hypothesis of AD, the role of various candidate genes for atherosclerosis has been investigated, leading to conflicting results. In order to clarify the significance of angiotensin-converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphism in a group of patients with sAD, we conducted a case-control study including 149 cases and 149 age and sex matched controls. All subjects were genotyped for ACE and Apolipoprotein E (APOE). There were no significant differences in ACE genotype or allele frequencies between ca…

MaleApolipoprotein ECandidate genemedicine.medical_specialtySettore MED/09 - Medicina InternaGenotypeDiseasePeptidyl-Dipeptidase ABiologyApolipoproteins EGene FrequencyAlzheimer DiseaseRisk FactorsInternal medicineGenetic predispositionmedicineHumansPolymorphismAllele frequencyAgedAged 80 and overPolymorphism GeneticNeuroscience (all)General NeuroscienceCase-control studyCase-control studyAngiotensin-converting enzymeMiddle AgedAlzheimer's diseasemedicine.diseaseEndocrinologyCase-Control Studiesbiology.proteinFemaleSettore MED/26 - NeurologiaApolipoprotein EAlzheimer's diseaseAngiotensin-converting enzymeNeuroscience Letters
researchProduct